A1 PHARMACEUTICALS HOLDINGS LIMITED
Get an alert when A1 PHARMACEUTICALS HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-01-31 (in 8mo)
Last filed for 2025-04-30
Confirmation statement due
2027-04-06 (in 11mo)
Last made up 2026-03-23
Watchouts
None on the register
Cash
£8M
+103.7% highest in 5 filed years
Net assets
£31M
+8.6% highest in 6 filed years
Employees
54
+3.8% highest in 6 filed years
Profit before tax
£3M
+52.3% vs 2024
Net assets
10-year trend · vs Health Care median
Accounts
10-year trend · latest reflected 2025-04-30
| Metric | Trend | 2020-04-30 | 2020-05-01 | 2021-04-30 | 2021-05-01 | 2022-04-30 | 2022-05-01 | 2023-04-30 | 2023-05-01 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | — | £55,982,183 | £60,102,403 | |
| Operating profit | — | — | — | — | — | — | — | — | £2,009,684 | £3,197,977 | |
| Profit before tax | — | — | — | — | — | — | — | — | £2,252,476 | £3,430,355 | |
| Net profit | £2,050,000 | — | £2,069,000 | — | £3,085,818 | — | £2,179,140 | — | £1,592,889 | £2,654,887 | |
| Cash | £1,075,705 | — | £1,080,020 | — | £1,080,020 | — | — | — | £3,828,006 | £7,799,024 | |
| Total assets less current liabilities | £4,106,000 | — | £6,106,000 | — | £9,106,000 | — | £11,102,000 | — | £29,058,950 | £31,558,109 | |
| Net assets | — | — | — | — | £9,106,000 | — | £11,102,000 | — | £28,921,942 | £31,415,022 | |
| Equity | £4,106,000 | £4,106,000 | £6,106,000 | £6,106,000 | £9,106,000 | £9,106,000 | £11,102,000 | £11,102,000 | £28,921,942 | £31,415,022 | |
| Average employees | 4 | — | 4 | — | 4 | — | 4 | — | 52 | 54 | |
| Wages | — | — | — | — | — | — | — | — | £1,816,217 | £2,002,638 | |
| Directors' remuneration | — | — | — | — | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-04-30 vs 2024-04-30
-
Turnover
+7.4%
£55,982,183 £60,102,403
-
Cash
+103.7%
£3,828,006 £7,799,024
highest in 5 filed years
-
Net assets
+8.6%
£28,921,942 £31,415,022
highest in 4 filed years
-
Employees
+3.8%
52 54
highest in 6 filed years
-
Operating profit
+59.1%
£2,009,684 £3,197,977
-
Profit before tax
+52.3%
£2,252,476 £3,430,355
-
Wages
+10.3%
£1,816,217 £2,002,638
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-04-30 | 2020-05-01 | 2021-04-30 | 2021-05-01 | 2022-04-30 | 2022-05-01 | 2023-04-30 | 2023-05-01 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | — | — | — | 3.6% | 5.3% | |
| Net margin | — | — | — | — | — | — | — | — | 2.8% | 4.4% | |
| Return on capital employed | — | — | — | — | — | — | — | — | 6.9% | 10.1% | |
| Gearing (liabilities / total assets) | — | — | — | — | — | — | — | — | 13.9% | 14.6% | |
| Current ratio | — | — | — | — | — | — | — | — | 7.32x | 6.95x | |
| Interest cover | — | — | — | — | — | — | — | — | 1412.29x | 1689.37x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Barnes Roffe Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's or the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- A1 PHARMACEUTICALS HOLDINGS LIMITED · parent
- A1 Pharmaceuticals plc 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LEWIS, Carmen | Director | 2013-04-30 | Jan 1965 | British |
| LEWIS, Gary Stephen | Director | 2013-04-30 | Feb 1960 | British |
| LEWIS, Henry Thomas John | Director | 2019-08-01 | Apr 1988 | British |
| LEWIS, Thomas William | Director | 2019-08-01 | Dec 1989 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mrs Carmen Lewis | Individual | Shares 25–50%, Voting 25–50%, Appoints directors, significant-influence-or-control-as-firm | 2025-11-21 | Active |
| Mr Gary Stephen Lewis | Individual | Shares 25–50%, Voting 25–50%, Appoints directors, significant-influence-or-control-as-firm | 2016-05-01 | Active |
Filing timeline
Last 20 of 45 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-04-15 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2025-11-21 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-11-21 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-11-04 | CH01 | officers | Change person director company with change date | |
| 2025-11-04 | CH01 | officers | Change person director company with change date | |
| 2025-11-04 | CH01 | officers | Change person director company with change date | |
| 2025-11-04 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-11-04 | CH01 | officers | Change person director company with change date | |
| 2025-10-31 | AA | accounts | Accounts with accounts type group | |
| 2025-03-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-31 | AA | accounts | Accounts with accounts type group | |
| 2024-04-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-31 | AA | accounts | Accounts with accounts type group | |
| 2023-04-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-07 | AA | accounts | Accounts with accounts type group | |
| 2022-03-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-28 | AA | accounts | Accounts with accounts type group | |
| 2021-06-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-10-29 | AA | accounts | Accounts with accounts type group |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 10
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.